Camp4 Therapeutics (CAMP) Revenue (2023 - 2026)

Camp4 Therapeutics has disclosed Revenue across 4 years of filings, most recently posting $1.3 million for Q1 2026.

• Revenue for Q1 2026 came in at $1.3 million, up 50.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 160.53% YoY), and the FY2025 annual result was $3.5 million, up 436.5% from the prior year.
• Revenue came in at $1.3 million for Q1 2026 at Camp4 Therapeutics, up from $348000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.5 million in Q2 2025 to a low of $348000.0 in Q4 2025.
• The 4-year median for Revenue is $795000.0 (2025), against an average of $827714.3.
• Across the five-year window, Revenue slumped 46.63% in 2025 and soared 50.82% in 2026, its largest moves.
• Camp4 Therapeutics' Revenue stood at $350000.0 in 2023, then surged by 86.29% to $652000.0 in 2024, then plunged by 46.63% to $348000.0 in 2025, then jumped by 271.84% to $1.3 million in 2026.
• The last three Revenue figures came in at $1.3 million (Q1 2026), $348000.0 (Q4 2025), and $795000.0 (Q3 2025), per Business Quant data.